Yaokang Bio Hits Daily Limit for Second Straight Session, Cumulatively Up 43.98%
Yaokang Bio surged by its daily price limit during trading on August 10, closing at RMB 39.97 per share, with turnover of RMB 353 million and a turnover rate of 2.23%. This marked the second consecutive limit-up session, bringing the two-day cumulative gain to 43.98%. On the STAR Market, 174 stocks rose, with 15 gaining over 5%, while 433 declined. Funds showed net inflow of RMB 66.772 million for Yaokang Bio on the prior trading day, and RMB 121 million over the past five sessions. Margin balance stood at RMB 77.108 million, down 6.76% over ten days.
Yaokang Bio hit its daily price limit during intraday trading on August 10, with the stock closing at RMB 39.97 per share. Turnover reached RMB 353 million, with a turnover rate of 2.23% and an amplitude of 10.90%. The stock has now recorded limit-up moves for two consecutive trading sessions, bringing its cumulative two-day gain to 43.98%.
Among STAR Market stocks, as of the time of writing, 174 stocks rose, of which 15 gained more than 5%. Yaokang Bio, Bide Pharmatech and Novoprotein led the gains, rising 19.99%, 15.67% and 14.28% respectively. Meanwhile, 433 stocks declined, with *ST Hangtu, Dongwei Technology and Xunjiexing suffering the largest losses, falling 11.56%, 7.31% and 5.35% respectively.
On the capital front, Yaokang Bio recorded net main capital inflow of RMB 66.772 million on the previous trading day, and RMB 121 million over the past five sessions. Margin trading data showed the stock's latest margin balance stood at RMB 77.108 million, comprising RMB 76.1238 million in margin buying, down RMB 20.6016 million or 21.30% from the prior session, and RMB 984,200 in short selling, up RMB 130,700 or 15.31%. Over the past ten sessions, the total margin balance decreased by RMB 5.5902 million, or 6.76%, with margin buying down 7.03% and short selling up 20.31% during the period.